ARCHIVES

Afinitor Increases Overall Survival To 3.5 Years in Phase III Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 9 | September 26, 2014

Download PDF Visit The Full Archive

Related Articles

Building Boom of Proton Beam Centers Flares Up in Washington and Baltimore

October 25, 2013

Vanderbilt-Ingram wins third SPORE grant.

September 19, 2003

Bioassay Backlog Catch Up Planned By Mid-February

August 26, 1977

In Brief: Huntsman Cancer Institute Joins NCCN: Howard cancer Center To Honor Mandela

November 7, 1997

UK Research Groups To Fund Virtual Tumor Bank

April 18, 2003

Also NIH institute directors earn higher salaries than Vice President Cheney; House subcommittee investigating pay of top NIH officials.

February 6, 2004